<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000043967">
  <TermName>6-hydroxymethylacylfulvene</TermName>
  <TermPronunciation>(6-hy-DROK-see-MEH-thul-AY-sel-FUL-veen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of some types of cancer. 6-hydroxymethylacylfulvene attaches to the cell's DNA and may block cancer cell growth. It is a type of alkylating agent. Also called irofulven.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000703961" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;6-hydroxymethylacylfulvene&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000703960" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;6-hidroximetilacilfulveno&quot;" language="es" id="_4"/>
  <SpanishTermName>6-hidroximetilacilfulveno</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. El 6-hidroximetilacilfulveno se une al ADN de la célula y puede bloquear el crecimiento de las células cancerosas. Es un tipo de alquilante. También se llama irofulveno.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2008-01-28</DateLastModified>
</GlossaryTerm>
